Humacyte, Inc. (HUMA) at a glance

Humacyte, Inc. (HUMA) is a micro-cap Healthcare company. It trades at $0.65, with a -376.1% profit margin and revenue decline of 4.3%. It does not pay a dividend. Vestovix scores it 28/100 overall. Its strongest dimension is Income (40/100) and its weakest is Safety (12/100). It carries above-market volatility, so expect larger swings.

Price

$0.65

Market cap

$234.2M

P/E ratio

n/a

Dividend yield

None

Beta

2.46

52-week range

$0.53 to $2.55